BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2021 7:56:20 AM | Browse: 410 | Download: 830
 |
Received |
|
2021-01-28 23:24 |
|
Peer-Review Started |
|
2021-01-28 23:29 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-06 06:38 |
|
Revised |
|
2021-03-20 12:27 |
|
Second Decision |
|
2021-07-13 03:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-13 08:08 |
|
Articles in Press |
|
2021-07-13 08:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-07-30 08:07 |
|
Publish the Manuscript Online |
|
2021-08-04 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Brittany B Dennis, Leen Naji, Yasmin Jajarmi, Aijaz Ahmed and Donghee Kim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Donghee Kim, MD, PhD, N/A, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto, CA 94034, United States. dhkimmd@stanford.edu |
| Key Words |
Hepatitis C virus; Direct-acting antivirals; Global health; Liver transplantation; People who inject drugs; Liver cirrhosis |
| Core Tip |
Hepatitis C virus (HCV) is a global health concern associated with significant morbidity and mortality. The introduction of well-tolerated oral direct-acting antiviral agents in late 2013 has revolutionized HCV management with over 90% cure rates. Equitable access to these agents remains an important issue, given that countries with the greatest burden of disease have the least access to curative therapies. Here we provide a literature review of HCV, changes in epidemiologic trends, current therapies, and highlight inequities in the burden of disease and access to treatment. |
| Publish Date |
2021-08-04 07:56 |
| Citation |
Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i29/4818.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i29.4818 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
